T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone

被引：11
|
作者：
Vercauteren, Suzanne M. [1 ,2 ,3 ]
Starczynowski, Daniel T. [2 ,3 ]
Sung, Sandy [2 ,3 ]
McNeil, Kelly [4 ]
Salski, Chris [4 ]
Jensen, Clara-Lynn [5 ]
Bruyere, Helene [3 ,5 ]
Lam, Wan L. [3 ,6 ]
Karsan, Aly [2 ,3 ,4 ]
机构：
[1] British Columbia Childrens Hosp, Pathol & Lab Med, Vancouver, BC V6H 3V4, Canada
[2] BC Canc Agcy, British Columbia Genome Sci Ctr, Vancouver, BC, Canada
[3] Univ British Columbia, Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada
[4] BC Canc Agcy, Canc Genet Lab, Vancouver, BC, Canada
[5] Vancouver Gen Hosp, Pathol & Lab Med, Vancouver, BC, Canada
[6] British Columbia Canc Agcy, Integrated Oncol Program, Vancouver, BC V5Z 4E6, Canada
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 156卷 / 03期
关键词：
myelodysplastic syndrome; T cell clonality; array; karyotype; ARRAY CGH ANALYSIS; MONOSOMY-7; RESOLUTION; LEUKEMIA; GENE;
D O I：
10.1111/j.1365-2141.2011.08872.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：409 / 412
页数：4
相关论文
共 50 条
  • [1] T Cells of Patients with Myelodysplastic Syndrome Are Frequently Derived From the Malignant Clone
    Vercauteren, Suzanne
    Starczynowski, Daniel T.
    Sung, Sandy
    McNeil, Kelly
    Salski, Chris
    Jensen, Clara-Lynn
    Bruyere, Helene
    Lam, Wan
    Karsan, Aly
    BLOOD, 2011, 118 (21) : 1211 - 1211
  • [2] Marrow stromal cells are not derived from the malignant clone in myelodysplastic syndromes (MDS).
    Awaya, N
    Rupert, K
    Bryant, E
    Torok-Storb, B
    BLOOD, 2001, 98 (11) : 353A - 353A
  • [3] Paroxysmal nocturnal hemoglobinuria clone in patients with myelodysplastic syndrome
    Yenerel, MN
    Diz-Kucukkaya, R
    Besisik, S
    Aktan, M
    Nalcaci, M
    Dincol, G
    Hacihanefioglu, A
    Turgut, M
    AMERICAN JOURNAL OF HEMATOLOGY, 2001, 68 (01) : 64 - 65
  • [4] CHARACTERIZATION OF MALIGNANT HEMATOPOIETIC STEM CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) IN A XENOGRAFT MODEL
    Medyouf, Hind
    Nolte, Florian
    Mossner, Maximilian
    Nowak, Verena
    Zens, Bettina
    Muedder, Katja
    Oblaender, Julia
    Fey, Stephanie
    Klaumuenzer, Marion
    Fabarius, Alice
    Mueller, Nadine
    Metzgeroth, Georgia
    Huetter, Gero
    Hofmann, Wolf Karsten
    Nowak, Daniel
    Trumpp, Andreas
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (08) : S42 - S43
  • [5] Clinical significance of regulatory T cells in patients with myelodysplastic syndrome
    Hamdi, Wedad
    Ogawara, Hatsue
    Handa, Hiroshi
    Tsukamoto, Norifumi
    Nojima, Yoshihisa
    Murakami, Hirokazu
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (03) : 201 - 207
  • [6] Red cell antibodies in frequently transfused patients with myelodysplastic syndrome
    Stiegler, G
    Sperr, W
    Lorber, C
    Fabrizii, V
    Höcker, P
    Panzer, S
    ANNALS OF HEMATOLOGY, 2001, 80 (06) : 330 - 333
  • [7] Red cell antibodies in frequently transfused patients with myelodysplastic syndrome
    Stiegler G.
    Sperr W.
    Lorber C.
    Fabrizii V.
    Höcker P.
    Panzer S.
    Annals of Hematology, 2001, 80 (6) : 330 - 333
  • [8] Expression patterns of chemokine receptors on circulating T cells from myelodysplastic syndrome patients
    Sand, Kristoffer Evebo
    Rye, Kristin Paulsen
    Mannsaker, Bard
    Bruserud, Oystein
    Kittang, Astrid Olsnes
    ONCOIMMUNOLOGY, 2013, 2 (02):
  • [9] The biological characteristics of Osteoblasts derived from myelodysplastic syndrome patients
    Chen, Wen-ming
    Chen, Zi-xing
    Cen, Jian-nong
    He, Jun
    Jiao, Xiao-li
    Wu, Ya-fang
    Zhang, Jun
    Qiu, Qiao-cheng
    Dai, Lan
    BLOOD, 2007, 110 (11) : 94B - 94B
  • [10] Development of myeloma and secondary myelodysplastic syndrome from a common clone
    Schmetzer, HM
    Mittermuller, J
    Duell, T
    Wilmanns, W
    CANCER GENETICS AND CYTOGENETICS, 1998, 100 (01) : 31 - 35
12345